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Here we describe a series of 5 cases in which RDN was performed in patients with
ESRD and resistant hypertension. The RF energy was delivered using the standard RF
delivery system that is used in cardiac electrophysiology lab and a standard 5F, 4mm tip
RF ablation catheter was used. Additionally multiple 3 dimensional imaging and catheter
monitoring modalities were used to precisely pinpoint the site of RF energy delivery. Dyna
CT, a novel 3D imaging tool was used to precisely define the anatomy and annotate the
radiofrequency lesions given in a spiral fashion along the length of the arteries. In addition,
non fluoroscopic anatomy was created using the NavX Version 3 system.
The procedure was completed without any complications in all 5 patients. The average
procedure time was 28 min and average of 5.6 lesions was given in each renal artery. Post
procedure renal parameters did not show any significant difference at 48 hrs and at 1
month followup.
There was a significant drop in blood pressure in all the patients 38  18 mmHg in
systolic and 16 14 mmHg fall in diastolic BP at 1week follow up and 39 22 mmHg
systolic , 18  13 mmHg fall in diastolic BP at 1 month follow up.
To the best of our knowledge, this is the first time in the world that such precision
technology has been used to guide this promising new therapy. This also is amongst the
first case series of renal failure patients treated with renal denervation. This is also the first
report of usage of standard RF ablation catheters for renal denervation and has the
potential of widespread usage in labs already equipped with EP systems without any
additional expenditure.
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Catheter Ablation of Hemodynamically Unstable Ventricular Tachycardia under
Support of Left Ventricular Assist Device
Fei Lu, Ioanna Apostolidou, Kenneth Liao, Ranjit John, Peter Eckman, Gladwin Das,
David Benditt, Daniel Garry
University of Minnesota, Minneapolis, MN
Background: Although hemodynamically unstable ventricular tachycardia (VT) may be
ablated with the aid of mechanical hemodynamic support, little is known regarding the
impact of possible hypo-perfusion of vital organs during such procedures.
Objective: This study investigated whether catheter ablation of unstable VT in the
presence of mechanical hemodynamic support may cause acute renal injury.
Methods: Between April 22 2009 and September 14 2012, 15 consecutive patients (aged
63 12 years with left ventricular ejection fraction of 19 9%) who underwent ablation
of hemodynamically unstable VT were included in this study. Hemodynamic support
included percutaneous (Impella, n5) and implantable (n7) left ventricular assist device
(LVAD) and percutaneous cardiopulmonary bypass (CPB, n5).
Results: Except for 2 case in which Impella® was used, hemodynamic support was
considered adequate (with consistent mean blood pressure of 60 mmHg). VT was
terminated at least once during ablation in all patients. Hemolysis was observed in 1
patient with Impella, and failure to insert Impella due to access problem was encountered
in another. Surgical intervention was needed in 2 patients with Impella due to bleeding
and entangled Preclose® device, respectively. The mean time under hemodynamic support
was 243  96 minutes, and time in VT was 98  67 minutes. There was no significant
change in creatinine, blood urea nitrogen, or glomerular filtration rate (GFR) at days 1
and 3 after the procedure compared to baseline values in all patients except one using
Impella with bleeding and inadequate hemodynamic support.
Conclusion: Our data suggest that percutaneous CPB and implantable LVAD provide
adequate hemodynamic support for ablation of unstable VT as evidenced by unchanged
renal function after procedure. Impella, on the other hand, was associated with more
complication risk, and may not provide sufficient hemodynamic support in unstable VT
patients.
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Efficacy and Safety of Adjuvant Proximal Balloon Inflation Comprising Stent
Proximal Edge for Full Expansion of the Stent by Stent Balloon
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Jin Oh Na, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim,
Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of
Background: Another shorter & bigger non-compliant balloon is being used for optimal
expansion of the stent, particularly the proximal portion of the stent when the proximal
and distal reference vessel diameters(RVD) are significantly different. The safety and
efficacy of adjuvant proximal balloon inflation (PBI) comprising proximal edge of the stent
using stent balloon with higher inflation pressure are largely unknown. This strategy was
intended to reduce procedural time, contrast amount and cost when we do the adjuvant
ballooning for optimal stent expansion.
Methods: This study consisted of 2164 consecutive patients (pts) underwent percuta-
neous coronary intervention (PCI) with drug-eluting stents (DESs). A total 211 pts (259
lesions) have performed PBI using same stent balloon. 6-month angiographic and
12-months clinical outcomes were compared between the PBI group and non-PBI group.
Results: The baseline clinical and procedural characteristics were balanced between the
two groups, except that the left circumflex lesions were more common in the PBI group.
There was no difference in procedural success rate and in hospital complications between
the two groups, except that the incidence of peri-procedural myocardial infarction (MI,
5.8% vs. 10.4%, P0.001) was higher in the PBI group. At 6-month, the follow up
minimal luminal diameter (MLD) was smaller in the PBI group. However, this
angiographic benefit was not translated into the clinical benefit up to 12 months. (Table).
Conclusion: PBI was associated with higher incidence of peri-procedural MI but other
safety profiles, procedural success, in-hospital complications, mid-term angiographic and
clinical outcomes were similar with those of non-PBI group. PBI can be a cost-effective
strategy when the proximal and distal RVD are significantly different at the time of stent
implantation.
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Moises Rodriguez-Regino, Violeta Valencia, Miguel Ramirez-Aldaraca,
Victor Manuel Diaz de Anda
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Objective: A) patency of the pulmonary arteries by thrombus aspiration with right
coronary guide catheter. B) Improve the function of the right ventricle. Reduce mortality.
Material: A total of 38 patients, 20 female and 18 male between 28 and 64 years from
March 2009 to April 2012. In 37 patients the obstruction was bilateral in all patients, the
degree of obstruction was greater than 80% of the main branches. In all cases, introducing
a long metal 8 french by 80cm in length and 8 french catheter coronary Judkins guide and
a 20ml syringe. the diagnosis was formulated with pulmonary angiotomography echocar-
diogram.
Method: By puncturing the femoral vein was placed a metal sheath of 8 french by 80cm
in length to the trunk of the pulmonary artery and this was passed through a guide
catheter handle 4 Judkin right coronary to the site of thrombosis and 20ml syringe practice
is sustained suction catheter to remove it slowly withdrawing the introducer. subsequently
purging the catheter to remove thrombi were aspirated. This maneuver was repeated
several times and finally a practical handbook with this catheter angiography to confirm
the patency of the pulmonary branches.
Results: In all cases it was possible achievement for all thrombi. was obtained
permeability of the pulmonary branches of 80% saturation was restored and blood pressure
in the next few hours. Of the 38 patients, one died during the procedure and another
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patient had hemoptysis. The procedure had a mortality rate of 2.63% and a morbidity of
2.63%.
Conclusion: This is an effective technique for the treatment of acute pulmonary
embolism reproducible high-risk low-cost and reestablished blood pressure, oxygen
saturation and right ventricular function and struck morbidity significant.
Renal Denervation
CRT-132
Catheter-based Renal Denervation Lowers Blood Pressure in Obese, Hypertensive
Canines
Jeffrey R Henegar,1 Yongxing John Zhang,2 Rita De Rama,2 Cary Hata,2
John E Hall1
1University of Mississippi Medical Center, Jackson, MS; 2St. Jude Medical, Irvine, CA
Obesity is associated with significant increases in arterial blood pressure, heart rate, and
glomerular filtration rate (GFR). Previous studies have shown that obesity-induced
hypertension is due, in part, to increased renal sympathetic activity which causes sodium
and water retention. Recently, catheter-based renal denervation (RD) has been reported
to lower arterial blood pressure in humans with ‘resistant’ hypertension. The current study
was designed to test if RD lowers arterial blood pressure in obese, hypertensive canines.
Obesity hypertension was created in mongrel hounds by feeding them a high fat diet for
five weeks. Blood pressure and heart rate were measured 24-hours per day using arterial
catheters and GFR with 125I-iothalamate clearance. After two weeks of control (Con)
measurements, bilateral RD was performed in nine canines by radiofrequency ablation
from within the renal arteries using the St. Jude Medical EnligHTNTM renal denervation
system. Following RD, blood pressure was measured continuously for eight weeks and
GFR was measured bi-weekly for six weeks. At the end of the eight-week period, both left
and right renal arteries were collected for histological analysis, and kidney samples were
obtained for renal catecholamine evaluation. Mean arterial pressure decreased from 109
2 mmHg in the Con period to 99 2 mmHg after RD (p0.01). The largest change was
seen in systolic blood pressure which fell from 157 5 mmHg during the Con period to
132 2 mmHg after RD ( p0.01). RD lowered diastolic blood pressure from 89  2
mmHg to 85 2 mmHg (p0.01). There were no significant changes in heart rate (Con
96  3 vs. RD 103  6 beats per minute) or GFR (Con 90.5  5.3 vs. RD 90.3  3.6
mL/min). RD caused injury in at least 42% of the renal nerves observed and reduced renal
tissue catecholamine by 47% (p0.01). Histological examination of the renal arteries
revealed minor endothelial and medial fibrosis in areas of the lesions and no signs of renal
arterial stenosis were observed. Thus, catheter-based renal denervation lowers blood
pressure in obese canines without compromising renal function or vascular integrity.
VALVE & STRUCTURAL HEART
Aortic Valve
CRT-133
Predictor That Influence The Degree Of Severity Of Mitral Regurgitation Post
Transcatheter Aortic Valve Replacement Using Edward Sapien Valve
Saad Mohamed Al Kasab,1 Saeed Awadh AlAhmari,1 Hussein Saeed AlAmri,1
Mohammed AlKasab,2 Ali AlMasood1
1Prince Sultan Cardiac Center, Riyadh, Saudi Arabia 2King Saud University, Riyadh,
Saudi Arabia
Background: Mitral Regurgitation (MR) is frequent finding in patient (Pt.) with Aortic
stenosis (AS). The study objective is to know the predictor that influences the change in
degree of MR severity post Transcatheter Aortic Valve Implantation (TAVI).
Method: Between April 2009 - January 2012, 50 consecutive patients with Aortic
Stenosis underwent (TAVI) procedure with Edward-Sapien Valve in PSCC. MR
assessed by visual mapping flow.
They were divided into two groups G1 (MR improved after TAVI) G2 (MR did not
improved after TAVI).
Results: Procedural success 96%
Character of patient and Hemodynamic and Echocardiography finding
CHARACTER G1 G2 P.V
Age
Gender F 78.1 10 77 9
M 15 10 NS
EFIOLOGY OF MR 12 13 NS
FUNCTIONAL 13 11 NS
ORGANIC 12 9 NS
MEDICAL HISTORY 11 19 (S)
(0.030)
HYPERTENSION 14 21 NS
DM 12 17 NS
CAD
PROCEDURE APPROACH 17 11 NS
TF - FEMORAL 10 12 NS
TA – APICAL 50 48 NS
PRE-MEAN AV GRADIENT 102 123 NS
POST-MEAN AV GRADIENT 40 37.66 NS
DEGREE OF MEAN AVERAGE CHANGE 535 546 NS
PRE LV EJECTION FRACTION 546 507 NS
POST LV EJECTION FRACTION 446 4010 NS
PRE PULMONARY ARTERY PRESSURE 375 3911 NS
POST PULMONARY ARTERY PRESSURE(PAP)
DEGREE OF PAP CHANGE
8.310 18 S.041
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